BioCardia, Inc.
BCDA
$0.83
-$0.05-6.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.26M | -1.98M | -1.48M | -2.05M | -2.71M |
| Total Depreciation and Amortization | 3.00K | 3.00K | 4.00K | 5.00K | 12.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 234.00K | 267.00K | 180.00K | 197.00K | 291.00K |
| Change in Net Operating Assets | 363.00K | -783.00K | -373.00K | 198.00K | 791.00K |
| Cash from Operations | -1.66M | -2.50M | -1.67M | -1.65M | -1.62M |
| Capital Expenditure | -3.00K | -6.00K | 0.00 | -1.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -6.00K | 0.00 | -1.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 225.00K | 5.00K | 6.78M | 1.70M | 212.00K |
| Repurchase of Common Stock | -- | -197.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -108.00K | -96.00K | -804.00K | -14.00K | -16.00K |
| Cash from Financing | 117.00K | -288.00K | 5.98M | 1.68M | 196.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.55M | -2.79M | 4.31M | 31.00K | -1.42M |